MetaCap

Coherus Oncology Statistics

NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.3698-0.0173 (-4.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Coherus Oncology by the numbers

Coherus Oncology has a market capitalization of $57.1 million based on 154.54M shares outstanding. With trailing EPS of $-1.12, Coherus Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 61.8% below its 50-day average and 74.0% below its 200-day average.

Average daily trading volume is 1.80M shares, or about $664,570 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CHRS valuation vs. peer median

CHRS compared with the median of 8 peer companies
MetricCHRSPeer medianDifference
Market cap$57.15M$58.28M-2%
Avg. volume1.80M304.18K+491%

Peer median across 8 companies: OKYO, CGTX, AVXL, CSBR, NMRA, ATRA, TNYA, IMA.

Valuation

Market cap
$57.15M
Price / sales (latest FY)
1.36
EPS (TTM)
$-1.12

Price and trading

Previous close
0.3871
Open
0.3868
Day range
0.3628 – 0.4084
52-week range
0.3628 – 2.62
52-week change
-68.12%
Beta
—
Volume
2.52M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
57.15M
Forward Pe
-0.60
Eps
-1.12
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.62
Week52 Low
0.36
Avg Volume
1.80M
Shares Outstanding
154.54M
Ma50
0.97
Ma200
1.43
Earnings Date
Nov 9, 2026
Pct From52w High
-85.86%
Pct From52w Low
1.93%

Related